Get the full picture
Sign in to uncover key details.
Show More
Alterome
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
13480 Evening Creek Dr N Ste 450, San Di...Website
www.alterome.comRevenue
<$5 MillionIndustry
About Alterome
Alterome Therapeutics is a clinical-stage biotechnology company focused on transforming the lives of cancer patients through the discovery of precise therapies. Utilizing a structure-guided approach to drug discovery, the company develops targeted oncology therapies aimed at high-value oncogenic drivers with limited treatment options. Their advanced programs include first-in-class small molecules targeting challenging cancer targets such as AKT and KRAS. Driven by a commitment to innovation and collaboration, Alterome seeks to inspire hope and improve outcomes for individuals affected by cancer.Explore more
Alterome Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alterome
Compare insights from companies similar to Alterome, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alterome Tech Stack
A closer look at the technologies used by Alterome
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alterome
Sign Up For FreeTo access detailed company insights
Alterome Therapeutics is a clinical-stage biotechnology company focused on transforming the lives of cancer patients through the discovery of precise therapies. Utilizing a structure-guided approach to drug discovery, the company develops targeted oncology therapies aimed at high-value oncogenic drivers with limited treatment options. Their advance... Read More
